Contribution of hematocrit to early mortality after ischemic stroke

European Neurology

Volumn 58, Issue 4, 2007, Pages 233-238

  Sacco, Simona ^a   Marini, Carmine ^a   Olivieri, Luigi ^a   Pistoia, Francesca ^a   Carolei, Antonio ^a,b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Hematocrit; Ischemic stroke; Mortality

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; FEMALE; HEART ATRIUM FIBRILLATION; HEMATOCRIT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; COMMUNITY HEALTH PLANNING; FEMALE; HEMATOCRIT; HUMANS; ISCHEMIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STROKE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 36448964191     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107946     Document Type: Article

References (16)

1. Kannel WB, Gordon T, Wolf PA, McNamara P: Hemoglobin and the risk of cerebral infarction: the Framingham Study. Stroke 1972;3:409-420.
2. Tohgi H, Yamanouchi H, Murakami M, Kameyama M: Importance of the hematocrit as a risk factor in cerebral infarction. Stroke 1978;9:369-374.
3. Gagnon DR, Zhang TJ, Brand FN, Kannel WB: Hematocrit and the risk of cardiovascular disease - the Framingham study: a 34-year follow-up. Am Heart J 1994;127:674-682.
4. Wannamethee G, Perry IJ, Shaper AG: Haematocrit, hypertension and risk of stroke. J Intern Med 1994;235:163-168.
5. Diamond PT, Gale SD, Evans BA: Relationship of initial hematocrit level to discharge destination and resource utilization after ischemic stroke: a pilot study. Arch Phys Med Rehabil 2003;84:964-967.
6. Italian Acute Stroke Study Group: Haemodilution in acute stroke: results of the Italian haemodilution trial: Lancet 1988;1:318-321.
7. Matthews WB, Oxbury JM, Grainger KM, Greenhall RC: A blind controlled trial of dextran 40 in the treatment of ischaemic stroke. Brain 1976;99:193-206.
8. Ozaita G, Calandre L, Peinado E, Rodríguez-Antigüedad A, Bermelo F: Hematocrit and clinical outcome in acute cerebral infarction. Stroke 1987;18:1166-1168.
9. Feigin VL, Lawes CMM, Bennett DA, Anderson CS: Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurology 2003;2:43-53.
10. Carolei A, Marini C, Di Napoli M, Di Gianfilippo G, Santalucia P, Baldassarre M, De Matteis G, di Orio F: High stroke incidence in the prospective community-based L'Aquila Registry (1994-1998): First year's results. Stroke 1997;28:2500-2506.
11. World Health Organization: Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 9th Revision. Geneva, WHO, 1977, vol 1.
12. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
13. Perez-Trepichio AD, Furlan AJ, Little JR, Jones SC: Hydroxyethyl starch 200/0.5 reduces infarct volume after embolic stroke in rats. Stroke 1992;23:1782-1790.
14. Yanaka K, Camarata PJ, Spellman SR, McDonald DE, Heros RC: Optimal timing of hemodilution for brain protection in a canine model of focal cerebral ischemia. Stroke 1996;27:906-912.
15. Allport LE, Parsons MW, Butcher KS, MacGregor L, Desmond PM, Tress BM, Davis SM: Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology 2005;6:1382-1387.
16. Koenig W, Ernst E: The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 1992;94:93-107.